|
Volumn 86, Issue 4, 2001, Pages 476-480
|
Valve disease endocartis: Basics
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMOXICILLIN;
ANTIBIOTIC AGENT;
CEFTRIAXONE;
CEPHALOSPORIN DERIVATIVE;
GENTAMICIN;
PENICILLIN DERIVATIVE;
STREPTOMYCIN;
VANCOMYCIN;
ANTIINFECTIVE AGENT;
ALPHA HEMOLYTIC STREPTOCOCCUS;
ANTIBIOTIC PROPHYLAXIS;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
BACTERIAL ENDOCARDITIS;
BACTERIUM ISOLATION;
BLOOD CULTURE;
COAGULASE NEGATIVE STAPHYLOCOCCUS;
DRUG CHOICE;
DRUG USE;
ENTEROCOCCUS FAECALIS;
HEART VALVE PROSTHESIS;
HUMAN;
MICROBIOLOGICAL EXAMINATION;
PATHOGENESIS;
PRIORITY JOURNAL;
REVIEW;
STAPHYLOCOCCUS AUREUS;
STAPHYLOCOCCUS EPIDERMIDIS;
TREATMENT INDICATION;
EQUIPMENT;
METHODOLOGY;
MICROBIOLOGY;
PROFESSIONAL PRACTICE;
RECURRENT DISEASE;
SENSITIVITY AND SPECIFICITY;
STANDARD;
TIME;
VALVULAR HEART DISEASE;
ANTI-BACTERIAL AGENTS;
ANTIBIOTIC PROPHYLAXIS;
ENDOCARDITIS, BACTERIAL;
EQUIPMENT CONTAMINATION;
HEART VALVE DISEASES;
HEART VALVE PROSTHESIS;
HUMANS;
MICROBIOLOGICAL TECHNIQUES;
PROFESSIONAL PRACTICE;
RECURRENCE;
SENSITIVITY AND SPECIFICITY;
TIME FACTORS;
|
EID: 0035491438
PISSN: 13556037
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (23)
|
References (9)
|